Cardiff University, Division of Cancer and Genetics, Cardiff, Wales, United Kingdom.
Cardiff & Vale University Health Board, Department of Surgery, Cardiff, Wales, United Kingdom.
Clin Nutr ESPEN. 2020 Dec;40:220-225. doi: 10.1016/j.clnesp.2020.09.016. Epub 2020 Sep 29.
BACKGROUND & AIMS: This study aimed to determine the prognostic significance of low muscle volume (LMV) Bioelectrical Impedance Analysis (BIA), defined skeletal muscle index (SMI, Kg/m male ≤8.75, female ≤5.75) in patients undergoing potentially curative surgery for Oesophageal Cancer (OC).
A prospective study of 122 patients diagnosed with OC [median age 65 yr, 104 male, 65 neoadjuvant therapy] who underwent preoperative BIA (Maltron Bioscan 920). Primary outcome measure was Overall Survival (OS).
LMV was identified in 11 (9.0%) of patients, which was associated with low lean muscle mass (27.3 vs. 31.1 kg, p = 0.012), low body fat (8.8 vs.19.3 kg, p < 0.001), and greater total body water (72.2 vs. 62.2%, p = 0.001), and more open & close laparotomies (36.4 vs. 8.1%, p = 0.012). Median and 5-year OS was 16 months and 18.2% in LMV patients, compared with 51 months and 52.4% in non-sarcopenic patients (p = 0.002). On multivariable analysis of pre-operative variables, only LMV (HR 2.75; 95% CI 1.33-5.66, p = 0.006) was associated with OS.
BIA is an important prognostic indicator in OC and focused pre-habilitation consequently has strong potential.
本研究旨在确定低肌肉量(LMV)生物电阻抗分析(BIA)的预后意义,即定义为男性骨骼肌指数(SMI,Kg/m ≤8.75,女性 ≤5.75),用于接受潜在根治性手术治疗的食管癌(OC)患者。
前瞻性研究了 122 例诊断为 OC 的患者[中位年龄 65 岁,104 例男性,65 例新辅助治疗],这些患者接受了术前 BIA(Maltron Bioscan 920)检测。主要观察指标是总生存率(OS)。
11 例(9.0%)患者存在 LMV,这与低瘦肌肉量(27.3 与 31.1kg,p=0.012)、低体脂肪量(8.8 与 19.3kg,p<0.001)、更大的总体水量(72.2 与 62.2%,p=0.001)以及更多的剖腹手术(36.4 与 8.1%,p=0.012)相关。在 LMV 患者中,中位和 5 年 OS 分别为 16 个月和 18.2%,而非肌少症患者则为 51 个月和 52.4%(p=0.002)。在术前变量的多变量分析中,只有 LMV(HR 2.75;95%CI 1.33-5.66,p=0.006)与 OS 相关。
BIA 是 OC 的一个重要预后指标,因此有针对性的术前康复具有很强的潜力。